Robert Lorne Hopfner

Insider Reports History

Location
San Francisco, CA
Signature
/s/ Gregory S. Moss, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Robert Lorne Hopfner:

Company Role Class Num Shares Value Price $ Report Date Ownership
Evommune, Inc. Director, 10%+ Owner Common Stock 1,632,441 $30,608,268 $18.75 19 Dec 2025 By Pivotal bioVenture Partners Fund I, L.P.
Evommune, Inc. Director, 10%+ Owner Common Stock 1,441,032 $27,019,350 $18.75 19 Dec 2025 By NFLS Delta III Limited
Evommune, Inc. Director, 10%+ Owner Common Stock 294,502 $5,521,912 $18.75 19 Dec 2025 By Pivotal bioVenture Partners Fund II, L.P.
Evommune, Inc. Director, 10%+ Owner Common Stock 4,026 $69,851 $17.35 19 Dec 2025 By Trust
Rallybio Corp Director Option (Right to Buy) 28,500 $51,500 $0.7000 13 May 2025 Direct
Rallybio Corp Director Option (Right to Buy) 16,500 $29,205 $1.77 15 May 2024 Direct
Inozyme Pharma, Inc. Director Common Stock 0 $0 $4.00 01 Jul 2025 By Pivotal
Vaxcyte, Inc. Director Stock Option (right to buy) 15,000 02 Jun 2021 Direct
Evommune, Inc. Director, 10%+ Owner Series A Preferred Stock 0 07 Nov 2025 By NFLS Delta III Limited
Evommune, Inc. Director, 10%+ Owner Series A Preferred Stock 0 07 Nov 2025 By Pivotal bioVenture Partners Fund I, L.P.
Evommune, Inc. Director, 10%+ Owner Series B Preferred Stock 0 07 Nov 2025 By NFLS Delta III Limited
Evommune, Inc. Director, 10%+ Owner Series B Preferred Stock 0 07 Nov 2025 By Pivotal bioVenture Partners Fund I, L.P.
Evommune, Inc. Director, 10%+ Owner Series C Preferred Stock 0 07 Nov 2025 By NFLS Delta III Limited
Evommune, Inc. Director, 10%+ Owner Series C Preferred Stock 0 07 Nov 2025 By Pivotal bioVenture Partners Fund II, L.P.
Evommune, Inc. Director, 10%+ Owner Series C Preferred Stock 0 07 Nov 2025 By Pivotal bioVenture Partners Fund I, L.P.
Evommune, Inc. Director, 10%+ Owner Series Seed Preferred Stock 0 07 Nov 2025 By NFLS Delta III Limited
Evommune, Inc. Director, 10%+ Owner Series Seed Preferred Stock 0 07 Nov 2025 By Pivotal bioVenture Partners Fund I, L.P.
Evommune, Inc. Director, 10%+ Owner Series Seed Preferred Stock 0 07 Nov 2025 By Trust

Insider Reports Filed by Robert Lorne Hopfner

Symbol Company Period Transactions Value $ Form Type Role Filing Time
/report/000101297525000937-hopfner-robert-lorne-2025-12-19 Evommune, Inc. 19 Dec 2025 1 +$17,350 4 Director, 10%+ Owner 22 Dec 2025, 07:07
/report/000155196625000007-hopfner-robert-lorne-2025-11-07 Evommune, Inc. 07 Nov 2025 14 $0 4 Director, 10%+ Owner 12 Nov 2025, 16:19
/report/000155196625000005-hopfner-robert-lorne-2025-11-05 Evommune, Inc. 05 Nov 2025 0 $0 3 Director, 10%+ Owner 05 Nov 2025, 20:05
INZY Inozyme Pharma, Inc. 01 Jul 2025 2 -$17,979,404 4 Director 03 Jul 2025, 18:59
RLYB Rallybio Corp 13 May 2025 1 $0 4 Director 15 May 2025, 17:06
RLYB Rallybio Corp 02 Jan 2025 1 +$51,500 4 Director 06 Jan 2025, 17:06
INZY Inozyme Pharma, Inc. 18 Jun 2024 1 $0 4 Director 20 Jun 2024, 16:15
RLYB Rallybio Corp 15 May 2024 1 $0 4 Director 17 May 2024, 17:03
INZY Inozyme Pharma, Inc. 01 Aug 2023 2 +$3,999,998 4 Director 03 Aug 2023, 20:01
INZY Inozyme Pharma, Inc. 13 Jun 2023 1 $0 4 Director 15 Jun 2023, 16:05
RLYB Rallybio Corp 17 May 2023 1 $0 4 Director 19 May 2023, 17:24
INZY Inozyme Pharma, Inc. 11 May 2023 2 +$2,849,998 4 Director 15 May 2023, 17:06
INZY Inozyme Pharma, Inc. 29 Mar 2023 1 +$1,563,724 4 Director 30 Mar 2023, 17:46
INZY Inozyme Pharma, Inc. 27 Mar 2023 2 +$841,063 4 Director 29 Mar 2023, 19:30
INZY Inozyme Pharma, Inc. 10 Jun 2022 1 $0 4 Director 14 Jun 2022, 07:49
RLYB Rallybio Corp 24 May 2022 1 $0 4 Director 26 May 2022, 20:09
INZY Inozyme Pharma, Inc. 19 Apr 2022 1 +$3,948,300 4 Director 20 Apr 2022, 16:05
RLYB Rallybio Corp 03 Jan 2022 1 $0 4 Director 05 Jan 2022, 19:44
RLYB Rallybio Corp 29 Jul 2021 0 $0 3 Director 29 Jul 2021, 19:35
RLYB Rallybio Corp 28 Jul 2021 4 +$7,499,999 4 Director 04 Aug 2021, 17:52
INZY Inozyme Pharma, Inc. 23 Jun 2021 1 $0 4 Director 24 Jun 2021, 16:12
PCVX Vaxcyte, Inc. 02 Jun 2021 1 $0 4 Director 03 Jun 2021, 18:51